Development of diabetes mellitus and hypertension due to aggravation of insulin resistance after estrogen--progestogen in HAIR-AN syndrome.
Vaidya
R A
RA
Bharatiya Vidya Bhavan's SPA Research Center, 13th NS Rd., Juhu, VileParle (W), Mumbai 400 049.
Shringi
M S
MS
Vaidya
A B
AB
Gogate
J G
JG
D000052:Acanthosis Nigricans / Q000188:drug therapy*; D000293:Adolescent; D000726:Androgen Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects* / Q000627:therapeutic use; D017373:Cyproterone Acetate / Q000009:adverse effects* / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000139:chemically induced*; D045166:Estradiol Congeners / Q000009:adverse effects* / Q000627:therapeutic use; D004997:Ethinyl Estradiol / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006628:Hirsutism / Q000188:drug therapy*; D006801:Humans; D017588:Hyperandrogenism / Q000188:drug therapy*; D006973:Hypertension / Q000139:chemically induced*; D007333:Insulin Resistance; D045167:Progesterone Congeners / Q000009:adverse effects* / Q000627:therapeutic use; D013577:Syndrome
D000726:Androgen Antagonists; D003277:Contraceptives, Oral, Combined; D045166:Estradiol Congeners; D045167:Progesterone Congeners; D004997:Ethinyl Estradiol; D017373:Cyproterone Acetate